Yanju Ma
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 6
- TGF-β signaling in diseases 3
- Cell death mechanisms and regulation 3
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Yunpeng Liu (23 shared papers)Xiujuan Qu (22 shared papers)Ye Zhang (14 shared papers)Ling Xu (13 shared papers)Ce Li (10 shared papers)Xiaofang Che (9 shared papers)Dan Zou (9 shared papers)Yibo Fan (10 shared papers)
- Journals
- Anti-Cancer Drugs (2 papers)Oncotarget (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2 papers)FEBS Letters (2 papers)The FASEB Journal (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Yanju Ma
41 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 268
- Oncology 234
- Molecular Biology 580
- Molecular Medicine 28
- Neurology 39
Countries citing papers authored by Yanju Ma
This map shows the geographic impact of Yanju Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanju Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanju Ma more than expected).
Fields of papers citing papers by Yanju Ma
This network shows the impact of papers produced by Yanju Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanju Ma. The network helps show where Yanju Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanju Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 73 | |
| 2 | 2007 | 58 | |
| 3 | 2018 | 57 | |
| 4 | 2020 | 56 | |
| 5 | 2012 | 51 | |
| 6 | 2015 | 47 | |
| 7 | 2019 | 46 | |
| 8 | 2020 | 45 | |
| 9 | 2014 | 38 | |
| 10 | 2017 | 36 | |
| 11 | 2017 | 35 | |
| 12 | 2014 | 33 | |
| 13 | 2017 | 32 | |
| 14 | 1998 | 30 | |
| 15 | 2015 | 29 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 26 | |
| 18 | 2015 | 25 | |
| 19 | 2021 | 23 | |
| 20 | 2013 | 22 |
About Yanju Ma
Yanju Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Molecular Medicine and Genetics, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), TGF-β signaling in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers), Cell death mechanisms and regulation (3 papers), Cell Adhesion Molecules Research (3 papers) and Curcumin's Biomedical Applications (3 papers). The work is most often cited by research in Cancer Research (268 citations), Oncology (234 citations), Molecular Biology (580 citations), Molecular Medicine (28 citations) and Neurology (39 citations). Yanju Ma has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yunpeng Liu, Xiujuan Qu, Ye Zhang, Ling Xu, Ce Li, Xiaofang Che, Dan Zou, Yibo Fan, Zhitao Jing and Yang Jiang. Their work appears in journals such as Anti-Cancer Drugs, Oncotarget, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, FEBS Letters and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.